Post Reply
41-51 of 51
I cut loss last year @ 0.13, losing a few thousands. It is my worst performing stock. I don't think it will be profitable in the near term, the EPO approval will probably takes thru 2008. Not vested, maybe in future.
Old report from MIDAS Research 2 May 2005
http://www.midasresearch.de/netengine/downloads/CR%20GMX%20E%20020505.pdf
Vested recently to keep...
IPO around $2; dunno when can achieve the former glory, man!
No wonder price rises sharply today; 1 marred deal 1.568 m during opening @ 0.095
Proposed strategic alliance and up to £32.1 million investment by Reliance Life Sciences Pvt Ltd
Proposed issue of New Ordinary Shares comprising Subscription Shares and Conversion Shares and proposed issue of a Warrant
Proposed cancellation of listing on the Official List and application to trading on AIM
Proposed Consolidation of Ordinary Shares
http://www.genemedix.com/restructuringfinal_20Dec06.pdf
How could this one be a hidden gem? Years after years the same old story of trying to get their 'invention' approved and keep incurring losses. But I like their 'never-say-die' spirit! Haahaa..... Surely, if they don't come up with somethings more concrete, many people are going to 'die' ! Cheers!!!
agreed, very risky.
will need to find out who the major company as announced in 25-08-06, [entered into temporary exclusive talks with a major company and was receiving bridging payments to fund its activities whilst negotiations take place]
hiring new stuff may not necessarily mean expansion, on the reverse, it may mean trying to replace attrition of employees bailing out...this counter is super high risk.
Volumes really low for this counter... TA traders should avoid
very interesting! but they have no more cash leh....thought about to close shop soon...?
this maybe in preparation for next year production when EPO[US 8B market] get approval from EMEA which is long overdue. wait for q3 results @ 27 nov
http://www.genemedix.com/vacancy13Nov06_pt.pdf